Efficacy of Esomeprazole in Patients With Frequent Heartburn

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will investigate the efficacy of esomeprazole 20 mg once a day in the treatment of frequent heartburn

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Esomeprazole

Criteria

Inclusion Criteria:

• Males and non-pregnant ,non-lactating females 18 years or older

• Experience heartburn at least 2 days a week

• Having heartburn that has responded to heartburn medication

• Must discontinue any current heartburn medications

Exclusion Criteria:

• Having a history of erosive esophagitis verified by endoscopy

• Having a history of GERD which was diagnosed by a physician

• Inability to take study medication or complete the study and all study procedures

• Subjects that have required more than one 14-day course of PPI treatment within the past 4 months